Evaluation of Anti-Hepatitis B Virus (HBV) Drugs Using the HBV Transgenic Mouse: Application of the Semiquantitative Polymerase Chain Reaction (PCR) for Serum HBV DNA to Monitor the Drug Efficacy
- 1 December 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 241 (1) , 43-48
- https://doi.org/10.1006/bbrc.1997.7766
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Lamivudine Is Effective in Suppressing Hepatitis B Virus Dna in Chinese Hepatitis B Surface Antigen Carriers: A Placebo–Controlled TrialHepatology, 1997
- Selection of Mutations in the Hepatitis B Virus Polymerase During Therapy of Transplant Recipients With LamivudineHepatology, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patientsAIDS, 1995
- Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue cultureAntimicrobial Agents and Chemotherapy, 1994
- Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse modelAntimicrobial Agents and Chemotherapy, 1992
- Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.Proceedings of the National Academy of Sciences, 1991
- An in vitro system for screening anti-hepatitis b virus drugsVirology, 1989
- Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent.Proceedings of the National Academy of Sciences, 1989
- Expression and replication of hepatitis B virus genome in transgenic mice.Proceedings of the National Academy of Sciences, 1989